mRNA Instability in the Nucleus Due to a Novel Open Reading Frame Element Is a Major Determinant of the Narrow Tissue Specificity of Folate Receptor α

REFERENCES

• Akahane, K., and D. H. Pluznik. 1992. Interleukin-4 inhibits interleukin-1 alpha-induced granulocyte-macrophage colony-stimulating factor gene expression in a murine B-lymphocyte cell line via downregulation of RNA precursor. Blood 79: 3188–3195.
   PubMed Web of Science ®Google Scholar
• Alberts, B., D. Bray, J. Lewis, M. Raff, K. Roberto, and J. D. Watson. 1989. Molecular biology of the cell, 2nd ed., chapter 9. Garland Publishing, Inc., New York, N.Y.
   Google Scholar
• Belgrader, P., J. Cheng, X. Zhou, L. S. Stephenson, and L. E. Maquat. 1994. Mammalian nonsense codons can be cis effectors of nuclear mRNA half-life. Mol. Cell. Biol. 14: 8219–8228.
   PubMed Web of Science ®Google Scholar
• Burkard, K. T. D., and J. S. Butler. 2000. A nuclear 3′-5′ exonuclease involved in mRNA degradation interacts with poly(A) polymerase and the hnRNA protein Np13p. Mol. Cell. Biol. 20: 604–616.
   PubMed Web of Science ®Google Scholar
• Campbell, I. G., T. A. Jones, W. D. Foulkes, and J. Trowsdale. 1991. Folate-binding protein is marker for ovarian cancer. Cancer Res. 51: 5329–5338.
   PubMed Web of Science ®Google Scholar
• Elwood, P. C., K. Nachmanoff, Y. Saikawa, S. T. Page, P. Pacheco, S. Roberts, and K. N. Chung. 1997. The divergent 5′ termini of the alpha human folate receptor mRNAs originate from two tissue-specific promoters and alternative splicing: characterization of the alpha hFR gene structure. Biochemistry 36: 1467–1478.
   PubMedGoogle Scholar
• Garber, M., S. Panchanathan, R. S. Fan, and D. L. Johnson. 1991. The phorbol ester, 12-O-tetradecanoylphorbol-13-acetate, induces specific transcription by RNA polymerase III in Drosophila Schneider cells. J. Biol. Chem. 266: 20598–20601.
   PubMedGoogle Scholar
• Goren, D., A. T. Horowitz, D. Tzemach, M. Tarshish, S. Zalipsky, and A. Gabizon. 2000. Nuclear delivery of doxorubicin via folate-targeted liposomes with bypass of multidrug-resistance efflux pump. Clin. Cancer Res. 6: 1949–1957.
   PubMed Web of Science ®Google Scholar
• Ikeda, E., M. G. Achen, G. Breier, and W. Risau. 1995. Hypoxia-induced transcriptional activation and increased mRNA stability of vascular endothelial growth factor in C6 glioma cells. J. Biol. Chem. 270: 19761–19766.
   PubMed Web of Science ®Google Scholar
• Jackman, A. L., D. S. Theti, A. S. Lornaime, and V. B. Bavetsias. 2000. Exploitation of the α-isoform of folate receptor (α-FR) for the selective delivery of antifolate thymidylate synthase (TS) inhibitors. In Proceedings of the 91st Annual Meeting of the American Association for Cancer Research. American Association for Cancer Research, Philadelphia, Pa.
   Google Scholar
• Konstantinova, I. M., V. A. Kulichkva, I. N. Evteeva, A. G. Mittenberg, I. V. Volko, J. B. Ermolaeva, and L. N. Gruse. 1999. The specific endoribonuclease activity of small nuclear and cytoplasmic alpha-RNPs. FEBS Lett. 462: 407–410.
   PubMedGoogle Scholar
• Lacey, S. W., J. M. Sanders, K. G. Rothberg, R. G. W. Anderson, and B. A. Kamen. 1989. Complementary DNA for the folate binding protein correctly predicts anchoring to the membrane by glycosyl-phosphatidylinositol. J. Clin. Investig. 84: 715–720.
   PubMed Web of Science ®Google Scholar
• Leamon, C. P., and P. S. Low. 2001. Folate-mediated targeting: from diagnostics to drug and gene delivery. Drug Discov. Today 6: 36–43.
   PubMedGoogle Scholar
• Lee, C. H., P. Leeds, and J. Ross. 1998. Purification and characterization of a polysome-associated endoribonuclease that degrades c-myc mRNA in vitro. J. Biol. Chem. 273: 25261–25271.
   PubMed Web of Science ®Google Scholar
• Leys, E. J., G. F. Crouse, and R. E. Kellems. 1984. Dihydrofolate reductase gene expression in cultured mouse cells is regulated by transcript stabilization in the nucleus. J. Cell Biol. 99: 180–187.
   PubMedGoogle Scholar
• Luiten, R. M., S. O. Warnaar, and D. Sanborn. 1997. Chimeric bispecific OC/TR monoclonal antibody mediates lysis of tumor cells expressing the folate-binding protein (Mov 18) and displays decreased immunogenicity in patients. J. Immunother. 20: 496–504.
   PubMed Web of Science ®Google Scholar
• Martinez, J., Y. G. Ren, A. C. Thuressou, U. Hellman, J. Astrom, and A. Virtanen. 2000. A 54-kDA fragment of the poly(A)-specific ribonuclease is an oligomeric, processive and cap-interacting poly(A)-specific 3′ exonuclease. J. Biol. Chem. 275: 24222–24230.
   PubMedGoogle Scholar
• Melani, C., M. Figini, and D. Nicosia. 1998. Targeting of interleukin 2 to human ovarian carcinoma by fusion with a single-chain Fv of antifolate receptor antibody. Cancer. Res. 58: 4146–4154.
   PubMed Web of Science ®Google Scholar
• Meskini, R. E., F. Boudouresque, and L. Ouafik. 1997. Estrogen regulation of peptidylglycine α-amidating monooxygenase messenger ribonucleic acid levels by a nuclear posttranscriptional event. Endocrinology 138: 5256–5265.
   PubMedGoogle Scholar
• Nakashima-Matsushita, N., T. Homma, S. Yu, T. Matsuda, N. Sunahara, T. Nakamura, M. Tsukano, M. Ratnam, and T. Matsuyama. 1999. Selective expression of folate receptor beta and its possible role in methotrexate transport in synovial macrophages from patients with rheumatoid arthritis. Arthritis Rheum. 42: 1609–1616.
   PubMed Web of Science ®Google Scholar
• Narayan, P., and H. C. Towle. 1985. Stabilization of a specific nuclear mRNA precursor by thyroid hormone. Mol. Cell. Biol. 5: 2642–2646.
   PubMedGoogle Scholar
• Peoples, G. E., B. W. Anderson, T. V. Lee, J. L. Murray, A. P. Kudelka, J. T. Wharton, and G. G. Ioannides. 1999. Vaccine implications of folate binding protein, a novel cytotoxic T lymphocyte-recognized antigen system in epithelial cancers. Clin. Cancer Res. 5: 4214–4223.
   PubMedGoogle Scholar
• Prendergast, G. C., and M. D. Cole. 1989. Posttranscriptional regulation of cellular gene expression by the c-myc oncogene. Mol. Cell. Biol. 9: 124–134.
   PubMed Web of Science ®Google Scholar
• Ratnam, M., H. Marquardt, J. L. Duhring, and J. H. Freisheim. 1989. Homologous membrane folate binding proteins in human placenta: cloning and sequence of a cDNA. Biochemistry 28: 8249–8254.
   PubMed Web of Science ®Google Scholar
• Roberts, S. J., K. N. Chung, K. Nachmanoff, and P. C. Elwood. 1997. Tissue-specific promoters of the alpha human folate receptor gene yield transcripts with divergent 5′ leader sequences and different translational efficiencies. Biochem. J. 326: 439–447.
   PubMed Web of Science ®Google Scholar
• Rodolfo, M., C. Melani, and C. Zilocchi. 1998. IgG2a induced by interleukin (IL) 12-producing tumor cell vaccines but not IgG1 induced by IL-4 vaccine is associated with the eradication of experimental metastases. Cancer Res. 58: 5812–5817.
   PubMedGoogle Scholar
• Ross, J. 1995. mRNA stability in mammalian cells. Microbiol. Rev. 59: 423–450.
   PubMedGoogle Scholar
• Ross, J. F., P. K. Chauduri, and M. Ratnam. 1994. Differential regulation of folate receptor isoforms in normal and malignant tissues in vivo and in established cell lines: physiologic and clinical implications. Cancer 73: 2432–2443.
   PubMed Web of Science ®Google Scholar
• Ross, J. F., H. Wang, F. G. Behm, P. Mathew, M. Wu, R. Booth, and M. Ratnam. 1999. Folate receptor type beta is a neutrophilic linear marker and is differentially expressed in myeloid leukemia. Cancer 85: 348–357.
   PubMed Web of Science ®Google Scholar
• Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
   Google Scholar
• Sudimack, J., and R. J. Lee. 2000. Targeted drug delivery via the folate receptor. Adv. Drug Deliv. Rev. 41: 147–162.
   PubMed Web of Science ®Google Scholar
• Tobler, A., C. W. Miller, K. R. Johnson, M. E. Selsted, G. Rovera, and H. P. Koeffler. 1988. Regulation of gene expression of myeloperoxidase during myeloid differentiation. J. Cell. Physiol. 136: 215–225.
   PubMed Web of Science ®Google Scholar
• Toffoli, G., C. Cernigo, A. Russo, A. Galls, M. Bagnoli, and M. Boiocchi. 1997. Overexpression of folate binding protein in ovarian cancers. Int. J. Cancer 74: 193–198.
   PubMed Web of Science ®Google Scholar
• Vaessen, R. T. M., A. Houweling, and A. J. Van der Eb. 1987. Post-transcriptional control of class I MHC mRNA expression in adenovirus 12-transformed cells. Science 235: 1486–1488.
   PubMedGoogle Scholar
• Vannice, J. L., J. M. Taylor, and G. M. Ringold. 1984. Glucocorticoid-mediated induction of α1-acid glycoprotein: evidence for hormone-regulated RNA processing. Proc. Natl. Acad. Sci. USA 81: 4241–4245.
   PubMed Web of Science ®Google Scholar
• Wang, H., X. Zheng, F. G. Behm, and M. Ratnam. 2000. Differentiation-independent retinoid induction of folate receptor type β, a potential tumor target in myeloid leukemia. Blood 96: 3529–3536.
   PubMed Web of Science ®Google Scholar
• Ward, C. M. 2000. Folate-targeted non-viral DNA vectors for cancer gene therapy. Curr. Opin. Mol. Ther. 2: 182–187.
   PubMed Web of Science ®Google Scholar
• Weitman, S. D., R. H. Lark, L. R. Coney, D. W. Fort, V. Frasca, V. R. Zurawski, and B. A. Kamen. 1992. Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues. Cancer Res. 52: 3396–3401.
   PubMed Web of Science ®Google Scholar
• Weitman, S. D., A. G. Weinberg, L. R. Coney, V. R. Zurawski, and D. Jennings. 1992. Cellular localization of the folate receptor: potential role in drug toxicity and folate homeostasis. Cancer Res. 52: 6708–6711.
   PubMed Web of Science ®Google Scholar
• Wu, M., W. Gunning, and M. Ratnam. 1999. Expression of folate receptor type alpha in relation to cell type, malignancy, and differentiation in ovary, uterus, and cervix. Cancer Epidemiol. Biomarkers Prev. 8: 775–782.
   PubMed Web of Science ®Google Scholar
• Yan, W., and M. Ratnam. 1995. Preferred sites of glycosylphosphatidylinositol modification in folate receptors and constraints in the primary structure of the hydrophobic portion of the signal. Biochemistry 3: 14594–14600.
   Google Scholar